Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Ixazomib (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Mercaptopurine; Methotrexate; Vincristine
- Indications Acute lymphoblastic leukaemia; Lymphoma
- Focus Adverse reactions
- 10 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Mar 2018.
- 15 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 03 Sep 2014 New trial record